111In-19G6

N/A

Report date: 2025/10/23 14:09:23

Base Information

Drug Name111In-19G6

Drug Alias Name111Indium-radiolabeled 19G6111In-DTPA-19G6

ClassificationRadiation-emitting products > Nuclides > Indium > 111InRadiation-emitting products > Radioactive diagnostic agentRadiation-emitting products > Radionuclide Drug Conjugates

Mechanisms of ActionMesothelin binders

TargetsMesothelin

Therapy Area/IndicationsOvarian Neoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryNetherlandsMainland China

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaPreclinical

Originator CompaniesHarbour Biomed

China Registration ClassN/A

Develop Information

Active CompaniesHarbour Biomed

Inactive CompaniesN/A

Active IndicationsOvarian Neoplasms

Inactive IndicationsN/A

Other Information

ATC CodeN/A